Felix Feng
Felix Feng
Professor of Radiation Oncology, Urology, and Medicine, University of California at San Francisco
Dirección de correo verificada de - Página principal
Citado por
Citado por
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
The landscape of long noncoding RNAs in the human transcriptome
MK Iyer, YS Niknafs, R Malik, U Singhal, A Sahu, Y Hosono, TR Barrette, ...
Nature genetics 47 (3), 199-208, 2015
DNA-repair defects and olaparib in metastatic prostate cancer
J Mateo, S Carreira, S Sandhu, S Miranda, H Mossop, R Perez-Lopez, ...
New England Journal of Medicine 373 (18), 1697-1708, 2015
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
IA Asangani, VL Dommeti, X Wang, R Malik, M Cieslik, R Yang, ...
Nature 510 (7504), 278-282, 2014
Identification of targetable FGFR gene fusions in diverse cancers
YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ...
Cancer discovery 3 (6), 636-647, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ...
Nature genetics 45 (11), 1392-1398, 2013
Radiation with or without antiandrogen therapy in recurrent prostate cancer
WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ...
New England Journal of Medicine 376 (5), 417-428, 2017
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose–effect relationships for the swallowing structures
FY Feng, HM Kim, TH Lyden, MJ Haxer, M Feng, FP Worden, ...
International Journal of Radiation Oncology* Biology* Physics 68 (5), 1289-1298, 2007
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
Mechanistic rationale for inhibition of poly (ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer
JC Brenner, B Ateeq, Y Li, AK Yocum, Q Cao, IA Asangani, S Patel, ...
Cancer cell 19 (5), 664-678, 2011
Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study
R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ...
Journal of Clinical Oncology 36 (24), 2492, 2018
Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial
WP Fendler, J Calais, M Eiber, RR Flavell, A Mishoe, FY Feng, ...
JAMA oncology 5 (6), 856-863, 2019
Integration of EGFR inhibitors with radiochemotherapy
MK Nyati, MA Morgan, FY Feng, TS Lawrence
Nature Reviews Cancer 6 (11), 876-885, 2006
Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer
YM Wu, M Cieślik, RJ Lonigro, P Vats, MA Reimers, X Cao, Y Ning, ...
Cell 173 (7), 1770-1782. e14, 2018
The bright side of dark matter: lncRNAs in cancer
JR Evans, FY Feng, AM Chinnaiyan
The Journal of clinical investigation 126 (8), 2775-2782, 2016
Dual Roles of PARP-1 Promote Cancer Growth and ProgressionDual Roles of PARP-1 in Tumor Growth and Progression
MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ...
Cancer discovery 2 (12), 1134-1149, 2012
Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results
FY Feng, HM Kim, TH Lyden, MJ Haxer, FP Worden, M Feng, JS Moyer, ...
Journal of Clinical Oncology 28 (16), 2732, 2010
Tobacco use in human papillomavirus–positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence
JH Maxwell, B Kumar, FY Feng, FP Worden, JS Lee, A Eisbruch, GT Wolf, ...
Clinical Cancer Research 16 (4), 1226-1235, 2010
A Hormone–DNA Repair Circuit Governs the Response to Genotoxic InsultA Hormone-DNA Repair Circuit Governs the Damage Response
JF Goodwin, MJ Schiewer, JL Dean, RS Schrecengost, R de Leeuw, ...
Cancer discovery 3 (11), 1254-1271, 2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20